Non-hormonal option to be made available for patients unsuitable for HRT
Source: PharmaTimes
You may also like
Bristol Myers Squibb’s New Drug Application for...
New Lung Model Reveals RSV Immune Response, Points to...
Mung Bean Pan-Genome Study Maps Key Genes for Yield...
Immune Evasion Uncovered by Virome-Wide Ubiquitin...
Genetic Map Opens Door to Development of New Therapies...
StockWatch: Insilico Projects Profit, Revenue Leaps as...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.